# OnCo record imiquimod (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/imiquimod/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "imiquimod" ;
  schema:name "Imiquimod"@en ;
  schema:description "Imiquimod (Aldara) is a cream that provokes the skin's own immune system to clear superficial basal cell carcinomas and the sun-damage patches (actinic keratoses) that can turn into skin cancer."@en ;
  schema:url <https://onco.cc/drugs/imiquimod/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Imiquimod> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=imiquimod>, <https://www.cancer.gov/about-cancer/treatment/drugs/imiquimod>, <https://www.ema.europa.eu/en/medicines/human/EPAR/aldara>, <https://doi.org/10.1016/S1470-2045(13)70530-8>, <https://doi.org/10.1016/j.jid.2016.10.019>, <https://doi.org/10.1016/j.jid.2017.09.033>, <https://doi.org/10.1002/14651858.CD003412.pub3> ;
  onco:status "approved" ;
  onco:tag "nci-list" ;
  onco:modality "Topical immune response modifier (TLR7 agonist)" ;
  schema:alternateName "Aldara / Zyclara" ;
  onco:approval "US 1997: External genital and perianal warts", "US 2004: Actinic keratosis; superficial basal cell carcinoma in immunocompetent adults", "EU 1998: Genital warts, superficial basal cell carcinoma and actinic keratosis (Aldara)" ;
  onco:cancers <https://onco.cc/cancers/basal-cell-carcinoma/>, <https://onco.cc/cancers/cutaneous-scc/>, <https://onco.cc/cancers/skin-cancer/> ;
  onco:technologies <https://onco.cc/technologies/chemoprevention/> ;
  onco:targets <https://onco.cc/targets/tlr7/> ;
  onco:companies <https://onco.cc/companies/bausch-health/> ;
  onco:terms <https://onco.cc/terms/histology/>, <https://onco.cc/terms/topical-and-destructive-treatment-bcc/> ;
  onco:trials <https://onco.cc/trials/sins-trial/>, <https://onco.cc/trials/mal-pdt-imiquimod-fluorouracil-superficial-bcc/>, <https://onco.cc/trials/scin-trial/> .